Dr Jeff Harrison

PhD GradCertClinEd DipClinPharm BSc(Hons)


Tertiary education

  • 2005 University of New South Wales, PG Cert (Clin Ed)
  • 2000 University of Bristol, PhD (Surgery)
  • 1994 University of Bath, PG Dip Clin Pharm
  • 1990 University of Aston, BSc Hons (Pharmacy)

Previous appointments

  • 2010 Regenstrief Institute/ Purdue University Visiting Professor
  • 2004- ongoing   University of Auckland Senior Lecturer
  • 2004- ongoing Waitemata DHB Clinical Pharmacist
  • 2003-2004 University of Auckland Senior Tutor (0.7wte)
  • 2003-2004 Enigma Publishing Ltd. Senior Editor, Decision Support (0.5wte)
  • 2001-2003 Clineanswers Ltd. Editorial Team Leader (Cardiovascular)
  • 1998-2001 North Staffordshire NHS Trust (UK) Clinical Information Manager / EBM
  • 1995-1998 University of Bristol (UK)  Research Associate
  • 1994-1995 Overseas Experience – not employed
  • 1991-1994 Southmead NHS Trust, Bristol (UK)  Clinical Pharmacist
  • 1990-1991 Royal Shrewsbury Hospital (UK)  Pre-registration Pharmacist

Research | Current

Research interests

  • Cardiovascular medicine
  • Evidence-based medicine
  • Computerised decision support
  • Rational use of medicines
  • Medication safety
  • Chronic disease management
  • Pharmaceutical care services
  • Ethics in healthcare
  • Professionalism
  • Organisational performance

Teaching | Current

Course coordinator

Contributing lecturer

  • OPTOMETRY 245 - Principles of Ocular Pharmacology
  • PHARMACY 301 - Pharmacy Practice 3
  • PHARMACY 407 - Integrated Pharmacy Studies 1
  • PHARMACY 408 - Integrated Pharmacy Studies 2
  • PHARMACY 409 - Profesisonal Pharmacy Practice
  • PHARMACY 410 - Research Dissertation
  • NURSING 722 - Therapeutics for Advanced Nursing
  • OPTOMETRY 781 – Principles of Ocular Disease
  • POPLPRAC 723 - Clinical Symptom Management in Palliative Care

Postgraduate supervision

Doctorate Student Research

  • Shane Scahill: PhD [2007 – 2011, Part-time converted to Full-time] Exploring the nature of the relationship between organisational culture and effectiveness within a selection of community pharmacies in New Zealand. Shane is the recipient of a competitive Senior Health Research Fellowship.Co-supervisior: Dr Peter Carswell, Health Systems
  • Amy Chan; PhD [2009 – 2014, Part-time]Improving adherence and asthma outcomes in individuals with poorly controlled asthma. Amy is the recipient of a Lottery Health Research Scholarship Co-supervisior: Professor Ed Mitchell, Medicine (Paediatrics)
  • Jerome Ng; PhD [2010 – 2013] An Exploratory Study into Measuring Medication Safety in New Zealand Hospitals. Jerome is the recipient of a competitive Senior Health Research Fellowship. Co-supervisor: Shane Scahill (Massey University). Advisor: Professor Alan Merry, Medicine (Anaesthesiology)
  • Primal Singh, PhD [2011 – 2014]The use of HMG Co-A enzyme inhibitors (statins) to reduce morbidity after colorectal surgery. Parry is the recipient of the Ruth Spencer Medical Research Fellowship. Co-supervisior: Associate Professoer Andrew Hill, Medicine (Surgery)

Masters Student Research

  • Sandra Ponen: MPH dissertation [2004/5] Validation of the Australasian Medicines and Devices Terminology (ADMT) model in the New Zealand setting
  • Damien Hannah: MPharmPrac dissertation [2005] Reliability of a Drug-Related Problem Classification System Used for Pharmacist Lead Medication Reviews for Elderly Rest Home Residents
  • Andre Mutavidzic: MPharmPrac Thesis [2005/6] Therapeutic Drug Monitoring at Waikato Hospital
  • Anne Blumgart: MPH thesis [2006/7] Examination of a structured patient education initiative to improve warfarin safety
  • Kathy Maxwell: MPharmPrac(Otago) [2010] Investigation of Drug Related Problems (DRP) in patients presenting with secondary care prescriptions: A New Zealand Community Pharmacy Perspective.
  • Karen Dunning: MHSc [2010] Clozapine discontinuation in New Zealand: a quantitative and qualitative review

International Exchange Student Masters Research

  • MPharm, Uppsala, Sweden, 2006/7 Elin Gisterå: Cardiovascular Risk Profile and Determinants of Risk in Mental Health Clients in New Zealand
  • MPharm, Uppsala, Sweden, 2007/8 Minna Janlöv: Descriptive review of clozapine prescribing in a mental health service in Auckland, New Zealand: comparison with national and international guidelines.
  • MPharm, Braunschweig, Germany, 2007/8 Stefanie Pügge:  A Systematic Review of Community Pharmacist Interventions to Improve Health Outcomes.
  • MPharm, Uppsala, Sweden, 2008/9 Elin Larsson: Physical health needs of patients with serious mental illness: a systematic review of the literature and development of a patient self-administered questionnaire.
  • MPharm, University of Nottingham, 2010 Kirsty Johnson: Prescription Medicines in Pregnancy: Prevalence of Use of Medicines with the Potential for Foetal Injury.
  • MPharm, Uppsala, Sweden, 2009/10 Patrick Bäckström: Assessment and management of CVD risk factors in a cohort of patients with serious mental illness.
  • MPharm, University of Nottingham, 2010 Riya Chopra: Does computerised decision support have the potential to improve practitioner adherence to guidelines for the management of Cardiovascular Disease and/or Diabetes in New Zealand?


  • 2010 Fulbright Senior Scholar Award, Fulbright New Zealand
  • 2007 Butland Award for Early Career Excellence in Teaching, FMHS

Committees/Professional groups/Services

  • International Society for Pharmacoepidemiology
  • American Society of Health System Pharmacists
  • Board of Pharmacotherapy Specialists (Certified)
  • Member of the United Kingdom Clinical Pharmacy Association
  • Member of the Royal Pharmaceutical Society of Great Britain
  • Pharmacy Council of New Zealand, Registered Pharmacist


  • Sub-professorial member of University Senate

External Academic, Government and Professional Bodies

  • Pharmacy Council of New Zealand
  • External Assessor (Undergraduate Pharmacy Programmes), School of Pharmacy, University of Queensland, Australia.
  • External Examiner, School of Pharmacy, University of Otago, New Zealand.
  • External Assessor (Postgraduate Professional Programmes), School of Pharmacy, University of Otago, New Zealand
  • Programme Accreditation Committee, Australian Pharmacy Council.
  • Editorial Board, Research in Social and Administrative Pharmacy

Selected publications and creative works (Research Outputs)

  • Bhusal, P., Sharma, M., Harrison, J., Procter, G., Andrews, G., Jones, D. S., ... Svirskis, D. (2017). Development, validation and application of a stability indicating HPLC method to quantify lidocaine from polyethylene-co-vinyl acetate (EVA) matrices and biological fluids. Journal of Chromatographic Science, 55 (8), 832-838. 10.1093/chromsci/bmx043
    URL: http://hdl.handle.net/2292/36714
    Other University of Auckland co-authors: Andrew Hill, Darren Svirskis, Manisha Sharma
  • Chan, A. H. Y., Stewart, A. W., Harrison, J., Black, P. N., Mitchell, E. A., & Foster, J. M. (2017). Electronic adherence monitoring device performance and patient acceptability: a randomized control trial. Expert review of medical devices, 14 (5), 401-411. 10.1080/17434440.2017.1322505
    Other University of Auckland co-authors: Alistair Stewart, Edwin Mitchell
  • Ng, J., Scahill, S., & Harrison, J. (2017). Getting the foundations right for the measurement of medication safety: The need for a meaningful conceptual frame. The New Zealand Medical Journal, 130 (1452), 54-62.
    Other University of Auckland co-authors: Jerome Ng, Shane Scahill
  • Wells, S., Riddell, T., Kerr, A., Pylypchuk, R., Chelimo, C., Marshall, R., ... Kyle, C. (2017). Cohort Profile: The PREDICT Cardiovascular Disease cohort in New Zealand primary care (PREDICT-CVD 19). International Journal of Epidemiology, 46 (1), 22-22j.
    URL: http://hdl.handle.net/2292/33279
    Other University of Auckland co-authors: Susan Wells, Corina Grey, Roger Marshall, Rodney Jackson, Patricia Metcalf, Carol Chelimo, Daniel Exeter, Romana Pylypchuk, Matire Harwood, Timothy Kenealy, Suneela Mehta, Jim Warren, Andrew Kerr
  • Shaw, J., Harrison, J., & Harrison, J. E. (2017). Evaluation of the Community Pharmacist-led Anticoagulation Management Service (CPAMS) Pilot Program in New Zealand. In Z. U. D. Barar (Ed.) (pp. 159-181). ELSEVIER ACADEMIC PRESS INC.
    Other University of Auckland co-authors: John Shaw
  • Kinsey, H., Scahill, S., Bye, L., & Harrison, J. (2016). Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement. International Journal of Pharmacy Practice, 24 (6), 379-389. 10.1111/ijpp.12266
    Other University of Auckland co-authors: Lynne Bye
  • Mehta, S., Wells, S., Jackson, R., Harrison, J., & Kerr, A. (2016). The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study. New Zealand Medical Journal, 129 (1443), 18-29.
    Other University of Auckland co-authors: Rodney Jackson, Susan Wells, Suneela Mehta, Andrew Kerr
  • Bhusal, P., Harrison, J., Sharma, M., Jones, D. S., Hill, A. G., & Svirskis, D. (2016). Controlled release drug delivery systems to improve post-operative pharmacotherapy. Drug Delivery and Translational Research, 6 (5), 441-451. 10.1007/s13346-016-0305-z
    URL: http://hdl.handle.net/2292/31111
    Other University of Auckland co-authors: Andrew Hill, Darren Svirskis, Manisha Sharma

Contact details

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 3, Room 331B
New Zealand

Secondary office location

TAMAKI BUILDING 730 - Bldg 730
Level 3 , Room 314
New Zealand